A theoretical insight into selectivity of inhibitors toward two domains of bromodomain-containing protein 4 using molecular dynamics simulations.

scientific article published on 15 November 2017

A theoretical insight into selectivity of inhibitors toward two domains of bromodomain-containing protein 4 using molecular dynamics simulations. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CBDD.13148
P698PubMed publication ID29139214

P50authorJianzhong ChenQ69398575
Xinguo LiuQ89264019
P2093author name stringJing Su
Qinggang Zhang
Shaolong Zhang
Fangfang Yan
P2860cites workRVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonistQ21132391
Histone recognition and large-scale structural analysis of the human bromodomain familyQ24310431
The bromodomain: a conserved sequence found in human, Drosophila and yeast proteinsQ24604489
Comparison of simple potential functions for simulating liquid waterQ26778447
Structures of the Dual Bromodomains of the P-TEFb-activating Protein Brd4 at Atomic ResolutionQ27657784
Suppression of inflammation by a synthetic histone mimicQ27665789
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomainQ27680635
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage ProgressionQ27684429
Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomainsQ27685477
4-Acyl pyrroles: mimicking acetylated lysines in histone code readingQ27687671
4-Acyl Pyrrole Derivatives Yield Novel Vectors for Designing Inhibitors of the Acetyl-Lysine Recognition Site of BRD4(1)Q27703416
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) ProteinsQ27703506
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 BromodomainsQ27704993
RVX-297- a novel BD2 selective inhibitor of BET bromodomainsQ27709485
The Amber biomolecular simulation programsQ27860745
Targeting epigenetic readers in cancerQ42714565
Evaluating the potency of HIV-1 protease drugs to combat resistanceQ43196448
Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA.Q43678172
Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge modelsQ45179427
Calculations of Solvation Free Energy through Energy Reweighting from Molecular Mechanics to Quantum MechanicsQ46595732
The IDP-Specific Force Field ff14IDPSFF Improves the Conformer Sampling of Intrinsically Disordered ProteinsQ46719351
Zinc ion-induced conformational changes in new Delphi metallo-β-lactamase 1 probed by molecular dynamics simulations and umbrella sampling.Q48359993
Characterizing the Free-Energy Landscape of MDM2 Protein-Ligand Interactions by Steered Molecular Dynamics SimulationsQ50905703
Effect of electrostatic polarization and bridging water on CDK2-ligand binding affinities calculated using a highly efficient interaction entropy method.Q51075716
Interaction Entropy: A New Paradigm for Highly Efficient and Reliable Computation of Protein-Ligand Binding Free EnergyQ51383023
Clarifying binding difference of ATP and ADP to extracellular signal-regulated kinase 2 by using molecular dynamics simulationsQ51437778
Fast and accurate computation schemes for evaluating vibrational entropy of proteins.Q51605931
Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulationsQ52465150
BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cellsQ53328142
Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoringQ54323649
Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systemsQ56750591
Comparison of multiple Amber force fields and development of improved protein backbone parametersQ27861040
The bromodomain: a chromatin-targeting module?Q28139513
Targeting bromodomains: epigenetic readers of lysine acetylationQ28238635
Gene duplications in the structural evolution of chymotrypsinQ28239251
Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discoveryQ28260105
A novel, mitogen-activated nuclear kinase is related to a Drosophila developmental regulatorQ28275590
Automated docking of flexible ligands: applications of AutoDockQ28285420
Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulationQ28539602
Predictions of Ligand Selectivity from Absolute Binding Free Energy CalculationsQ28818600
Development and testing of a general amber force fieldQ29547642
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validationQ29617869
An analysis of the interactions between the Sem-5 SH3 domain and its ligands using molecular dynamics, free energy calculations, and sequence analysis.Q30168058
Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.Q30333153
Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set.Q30835329
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory DataQ31026348
The structural basis of ATP as an allosteric modulatorQ34165655
A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.Q34428881
Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulationsQ34531578
Nonequivalent response to bromodomain-targeting BET inhibitors in oligodendrocyte cell fate decisionQ35208927
Small molecule inhibitors of bromodomain-acetyl-lysine interactionsQ35535791
Quantum and molecular dynamics study for binding of macrocyclic inhibitors to human alpha-thrombin.Q35812336
Probing Origin of Binding Difference of inhibitors to MDM2 and MDMX by Polarizable Molecular Dynamics Simulation and QM/MM-GBSA CalculationQ36329555
Accurate calculation of the absolute free energy of binding for drug moleculesQ36427764
Molecular dynamics simulations of hemoglobin A in different states and bound to DPG: effector-linked perturbation of tertiary conformations and HbA concerted dynamicsQ36494755
Large-scale molecular dynamics simulation: Effect of polarization on thrombin-ligand binding energyQ37163377
Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.Q37334404
Molecular Mechanism and Energy Basis of Conformational Diversity of Antibody SPE7 Revealed by Molecular Dynamics Simulation and Principal Component AnalysisQ37405719
Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.Q37691709
The bromodomain interaction moduleQ38019699
Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactionsQ38038217
Ligand Selectivity Mechanism and Conformational Changes in Guanine Riboswitch by Molecular Dynamics Simulations and Free Energy CalculationsQ38874308
A theoretical study on the molecular determinants of the affibody protein Z(Aβ3) bound to an amyloid β peptide.Q38997273
Differential flap dynamics in l,d-transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics.Q40222330
Ligand docking and binding site analysis with PyMOL and Autodock/VinaQ40898209
Thermodynamics calculation of protein-ligand interactions by QM/MM polarizable charge parametersQ41245086
Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: insight from microsecond molecular dynamics simulationsQ41458992
Numerical integration: a method for improving solution stability in models of the circulationQ41917104
Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from dockingQ41921801
Dual-activity PI3K-BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasisQ42320410
P4510describes a project that usesmolecular dynamics simulationQ901663
P433issue3
P304page(s)828-840
P577publication date2017-12-10
P1433published inChemical Biology and Drug DesignQ15749458
P1476titleA theoretical insight into selectivity of inhibitors toward two domains of bromodomain-containing protein 4 using molecular dynamics simulations
P478volume91

Reverse relations

cites work (P2860)
Q99413660BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma
Q90431599Conformational Flexibility of the Protein-Protein Interfaces of the Ebola Virus VP40 Structural Matrix Filament
Q58710194Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5

Search more.